INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

20,679 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
CL
Churchill David LawrenceDirector, CHIEF TECHNOLOGY OFFICER
BETABETA Technologies, Inc.
Open-market sale
SELL$689
38 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

Page 278 of 517
← PrevNext →
36
ZA
Zegna di Monte Rubello AngeloCo-CEO of the ZEGNA brand
ZGNErmenegildo Zegna N.V.
Open-market sale
SELL
$25K
1,935 sh
May 8, 2026
May 11, 2026
traded May 8, 2026
+3d
SEC Form 4

Evidence

36
RG
Rubenstein GordonDirector
ACELAccel Entertainment, Inc.
Open-market sale
SELL$201K
17.7K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

35
SJ
Stedke Trevor J.Sr. Vice President, Operations
ULCCFrontier Group Holdings, Inc.
Open-market sale
SELL$450K
83.1K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

35
WN
Ward Lynne N.Director
MMSIMERIT MEDICAL SYSTEMS INC
Open-market sale
SELL$313K
5,000 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

35
MC
Martens Robert C.SVP-Chief Innovation & Design
ALLEAllegion plc
Open-market sale
SELL$548K
3,993 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

33
KJ
Kenneweg JohnSVP, Sales & Product Marketing
MASS908 Devices Inc.
Open-market sale
SELL$148K
18.3K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

32
RG
Rubenstein GordonDirector
ACELAccel Entertainment, Inc.
Open-market sale
SELL$57K
4,946 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

31
RP
Richer Tobin PEVP Marketing & Communications
KAROPENLANE, Inc.
Open-market sale
SELL$153K
4,000 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

30
MM
Mindlin Marcos MarceloDirector, 10% Owner
PAMPampa Energy Inc.
Open-market sale
SELL$6.03M
1.80M sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

28
SR
Shefman RandySVP & General Counsel
RGLDROYAL GOLD INC
Open-market sale
SELL$244K
1,000 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

28
SM
Sentonas MichaelPRESIDENT
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$10.60M
20.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

28
RG
Rubenstein GordonDirector
ACELAccel Entertainment, Inc.
Open-market sale
SELL$92K
7,985 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

28
SM
Sentonas MichaelPRESIDENT
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$10.80M
20.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

26
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$449K
18.6K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

25
SM
Sentonas MichaelPRESIDENT
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$2.49M
4,980 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

23
Sylebra Capital LlcDirector
PIIMPINJ INC
Open-market sale
SELL$5.52M
36.2K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

20
FJ
Forsyth JohnDirector, CEO
CRUSCIRRUS LOGIC, INC.
Open-market sale · 10b5-1 plan
SELL$852K
5,000 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

20
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$15.82M
79.4K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
8,603 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.22M
6,048 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$2.18M
10.9K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.81M
9,108 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$3.03M
15.5K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$2.22M
11.4K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.67M
8,208 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$9.03M
45.5K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
5,677 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
8,603 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.81M
9,108 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$8.55M
43.0K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$5.56M
28.4K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
8,477 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$6.86M
34.2K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
5,678 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$1.81M
9,016 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

17
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$3.00M
14.9K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

16
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
4,321 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

16
SM
Sentonas MichaelPRESIDENT
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
20 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

16
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
6,979 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence